Literature DB >> 12133968

Critical role of NK cells rather than V alpha 14(+)NKT cells in lipopolysaccharide-induced lethal shock in mice.

Masashi Emoto1, Mamiko Miyamoto, Izumi Yoshizawa, Yoshiko Emoto, Ulrich E Schaible, Eiji Kita, Stefan H E Kaufmann.   

Abstract

Although macrophages play a central role in the pathogenesis of septic shock, NK1(+) cells have also been implicated. NK1(+) cells comprise two major populations, namely NK cells and V alpha 14(+)NKT cells. To assess the relative contributions of these NK1(+) cells to LPS-induced shock, we compared the susceptibility to LPS-induced shock of beta(2)-microglobulin (beta(2)m)(-/-) mice that are devoid of V alpha 14(+)NKT cells, but not NK cells, with that of wild-type (WT) mice. The results show that beta(2)m(-/-) mice were more susceptible to LPS-induced shock than WT mice. Serum levels of IFN-gamma following LPS challenge were significantly higher in beta(2)m(-/-) mice, and endogenous IFN-gamma neutralization or in vivo depletion of NK1(+) cells rescued beta(2)m(-/-) mice from lethal effects of LPS. Intracellular cytokine staining revealed that NK cells were major IFN-gamma producers. The J alpha 281(-/-) mice that are exclusively devoid of V alpha 14(+)NKT cells were slightly more susceptible to LPS-induced shock than heterozygous littermates. Hence, LPS-induced shock can be induced in the absence of V alpha 14(+)NKT cells and IFN-gamma from NK cells is involved in this mechanism. In WT mice, hierarchic contribution of different cell populations appears likely.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12133968     DOI: 10.4049/jimmunol.169.3.1426

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  NK but not CD1-restricted NKT cells facilitate systemic inflammation during polymicrobial intra-abdominal sepsis.

Authors:  Anthony O Etogo; Jesus Nunez; Cheng Y Lin; Tracy E Toliver-Kinsky; Edward R Sherwood
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

Review 2.  The role of innate immunity in HBV infection.

Authors:  Qiuju Han; Cai Zhang; Jian Zhang; Zhigang Tian
Journal:  Semin Immunopathol       Date:  2012-07-20       Impact factor: 9.623

Review 3.  Role of cellular events in the pathophysiology of sepsis.

Authors:  Chandra Bhan; Pankaj Dipankar; Papiya Chakraborty; Pranita P Sarangi
Journal:  Inflamm Res       Date:  2016-07-08       Impact factor: 4.575

4.  C5a regulates NKT and NK cell functions in sepsis.

Authors:  Michael E Fusakio; Javid P Mohammed; Yves Laumonnier; Kasper Hoebe; Jörg Köhl; Jochen Mattner
Journal:  J Immunol       Date:  2011-11-04       Impact factor: 5.422

Review 5.  Natural killer (NK) cells in antibacterial innate immunity: angels or devils?

Authors:  Fernando Souza-Fonseca-Guimaraes; Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

6.  Staphylococcal enterotoxin B in vivo modulates both gamma interferon receptor expression and ligand-induced activation of signal transducer and activator of transcription 1 in T cells.

Authors:  R Plaza; J L Rodriguez-Sanchez; C Juarez
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

7.  Beta2-microglobulin-dependent bacterial clearance and survival during murine Klebsiella pneumoniae bacteremia.

Authors:  Anna L Cogen; Thomas A Moore
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

Review 8.  NKT cells in sepsis.

Authors:  Briana Leung; Hobart W Harris
Journal:  Clin Dev Immunol       Date:  2010-10-04

Review 9.  The bioartificial kidney in the treatment of acute kidney injury.

Authors:  Joon Ho Song; H David Humes
Journal:  Curr Drug Targets       Date:  2009-12       Impact factor: 3.465

10.  Exacerbated type II interferon response drives hypervirulence and toxic shock by an emergent epidemic strain of Streptococcus suis.

Authors:  Claude Lachance; Marcelo Gottschalk; Pehuén P Gerber; Paul Lemire; Jianguo Xu; Mariela Segura
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.